For example, FABP1 enhances mitochondrial β-oxidation in hepatocellular carcinoma to provide energy[18], while FABP4 promotes breast cancer cells to take up fatty acids from adipocytes and activates the STAT3 pathway to drive epithelial-mesenchymal transition (EMT)[70]. This evidence concerns the gene FABP4 and breast cancer.